Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 7441 - 7448 of 12085 results

It’s Time to Prepare H-1B Visa Petitions for Fiscal Year 2018

January 18, 2017| Alert| Viewpoint

Reminder – New Form I-9

January 18, 2017| Alert| Viewpoint

Viability of Dutch Claims Foundations In Question

January 18, 2017| Blog| Viewpoint

Will FDA Adverse Event Data Release Mean More Lawsuits?

January 18, 2017| News

The FDA targeted DTC, video, unapproved drug promotion in 2016

January 18, 2017| News

New West Coast hire for Mintz

January 18, 2017| News

Health Care Enforcement Review And 2017 Outlook: Part 3

January 18, 2017| News

EB-5 Update Could Pump The Brakes On Investor Numbers

January 18, 2017| News

News & Press Releases

Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform

August 06, 2025

Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.

Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering

August 05, 2025

Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.

IP Strategist Daniel Brownstone Joins Mintz in New York

July 30, 2025

Daniel Brownstone has joined Mintz as a Member in the firm’s Intellectual Property Division, adding depth to the firm’s IP Prosecution Practice and contributing to its continued growth in the market. He will be based in the firm’s New York office.

View all News and Press Releases